Pramila Parajuli

Pramila Parajuli

Auto-generated profile, based on publicly available information

Pramila Parajuli

Department of Microbiology, St. Xavier’s College, Maitighar, Kathmandu, Nepal

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2020 in Journal of Tropical Medicine
Verified
Journal Article
Open access
PDF file
KSKusum Shrestha
Kusum Shrestha
ASAnil Kumar Sah
Anil Kumar Sah
NSNeetu Singh
Neetu Singh
PPPramila Parajuli
Pramila Parajuli
RARameshwar Adhikari
Rameshwar Adhikari
Introduction. Group B streptococci (GBS) are globally recognized as one of the leading causes of neonatal sepsis and meningitis and is also known to cause adverse pregnancy outcomes such as stillbirths and miscarriages. Thus, detailed investigation of GBS in pregnant women has special significance in public health related researches. Objectives. The present study is aimed at evaluating the prevalence of GBS colonization among pregnant women in Kathmandu city. Methods. The study was carried out among 125 pregnant women at their trimester (35–37 weeks) (during the time period between January and June in 2018). The prevalence was determined by the culture method in HiCrome Strep B Selective Agar Base and then by using the PCR technique. The serotypes were evaluated by multiplex PCR analysis, while the antibiotics susceptibility tests were performed using the disk diffusion method. Results. Among 125 samples studied, GBS were recorded in 24 samples (implying a prevalence of 19.2%). Furthermore, using the multiplex PCR, among 24 GBS-positive samples, 13 (54.17%) were found to be typeable while 11 (45.83%) were nontypeable. The most abundant serotype recorded in this study was type III (33.33) while the serotypes IV, V, VI, VII, and VIII were not found. Conclusion. The isolates were sensitive towards some antibiotics such as linezolid and ceftriaxone 100%, whereas penicillin 50% and vancomycin 75% but were resistant to tetracycline and ertapenem. Serotype III was found to be predominant in the samples collected during the study period. The observed prevalence was significantly associated with the gestational period, whereas no relationship was found for other risk factors.

23 September 2024 in Nepal Medical College Journal
Verified
Journal Article
Open access
PDF file
TOTek Raj Ojha
Tek Raj Ojha
ASAnil Kumar Sah
Anil Kumar Sah
GKGovind Lal Karn
Govind Lal Karn
PPPramila Parajuli
Pramila Parajuli
Pseudomonas aeruginosa is one of the most common causes of hospital-acquired infections. It threatens worldwide public health because of its intrinsic antibiotic resistance and virulence. In this context, this research aimed to determine the occurrence of P. aeruginosa in a clinical setting, examine its susceptibility to antibiotics, and detect the presence of virulence genes, viz. exoY, oprL and toxA in all isolates. It was a cross-sectional study carried out from June 2022 to December 2022. A total of 1356 clinical specimens were collected and processed in the laboratory for Gram staining, culture techniques, and biochemical tests. The Kirby-Bauer disk diffusion method was applied to examine the antibiotic susceptibility pattern and conventional PCR was used to detect the virulence genes in all confirmed P. aeruginosa isolates. 40.5% of specimens showed bacterial growth, of which only 3.02% were identified as P. aeruginosa. Among them, 61.0% were multidrug resistant and 29.2% were β-lactamase producers. Aztreonam (70.7%) was the most effective antibiotic. Among all P. aeruginosa isolates, 68.3% isolates were exoY positive, 61.0% were oprL positive and 56.1% were toxA positive. Strategic interventions are required to stop the emergence and spread of antimicrobial resistance as a result of the isolation of multidrug resistant (MDR) isolates carrying these virulence genes. This study can benefit the medical staff and the entire community in building a surveillance system and enhancing infection control procedures.

14 July 2025 in SXC Journal
Verified
Journal Article
Open access
PDF file
AAArchana Adhikhari
Archana Adhikhari
VMVed Prakash Mishra
Ved Prakash Mishra
PPPramila Parajuli
Pramila Parajuli
Bloodstream infections (BSIs) are among the leading causes of morbidity and mortality worldwide. In developing countries, rising cases are driven by changing epidemiology, antibiotic resistance, lack of standardized treatments, and inadequate diagnostics, which contribute to an increased rate of BSI-associated mortality. The main objective of this research was to identify multidrug-resistant (MDR), methicillin-resistant Staphylococcus aureus (MRSA) and extended-spectrum beta-lactamase (ESBL) producing bacteria isolated from blood specimens. The cross-sectional study was conducted in Alka Hospital, Lalitpur, from April to October 2023. A total of 737 blood specimens from suspected BSI patients were inoculated on BACTEC 9050 and subcultured on Blood agar and MacConkey agar. Bacteria were identified based on colony morphology and biochemical tests, and then the antibiotic susceptibility pattern was determined using the Kirby-Bauer disk diffusion method following CLSI 2018. ESBL production was detected by screening and phenotypic confirmatory tests, and methicillin-resistant S. aureus (MRSA) was detected using a Cefoxitin disc. Out of 737 specimens processed, 52 (7.06%) were culture-positive, with 37 (71.15%) Gram-negative bacteria and 15 (28.85%) Gram-positive bacteria. A total of 70.27% of Gram-negative isolates and 73.33% Gram positive isolates were found to be multidrug resistant (MDR). A total of 29.73% Gram-negative bacteria and 20% Grampositive bacteria were phenotypically confirmed as ESBL producers. MDR and ESBL-producing strains limit the treatment options. Therefore, strict regulations on antibiotic prescription and sales, and increased public awareness of their proper use must be implemented to prevent ineffective use, misuse and overuse, which drive the emergence of drug-resistant bacteria and exacerbate antimicrobial resistance.

31 December 2024 in Nepal Journal of Biotechnology
Verified
Journal Article
Open access
PDF file
ABAnisha Bhandari
Anisha Bhandari
KSKanti Shrestha
Kanti Shrestha
PPPramila Parajuli
Pramila Parajuli
Recently, there has been an increase in global acclaim for historically utilized medicinal plants. This study aimed to prepare 70% ethanolic extracts from various medicinal plants and evaluate their phytochemical profiles, antimicrobial properties, and antioxidant activities. Twelve medicinal plant samples (six flowers and six leaves of same medicinal plant) (Rhododendron arboreum, Hibiscus rosa sinensis, Rosa damascena, Tagetes erecta, Bougainvillea glabra and Chrysanthemum grandiflorum) were collected and processed. Standard procedures were employed to assess the phytochemical composition of these extracts. Antimicrobial activity was evaluated using the agar well diffusion method, while antioxidant capacity was determined using the DPPH (1,1-diphenyl-2-picrylhyrazyl) assay. Phytochemical screening revealed the presence of alkaloids, coumarin, glycosides, flavonoids, tannins, quinones, reducing sugars, and saponins in most of the extracts. Notably, R. damascena, T. erecta, and R. arboreum demonstrated antimicrobial activity against Staphylococcus aureus (ATCC 6538P), with R. damascena showing the strongest inhibition across all concentrations (100, 200, 300, and 400 mg/ml), with the highest inhibition zone of 20 mm at 400 mg/ml. However, no extracts displayed antibacterial activity against Klebsiella pneumoniae, Pseudomonas aeruginosa, or Escherichia coli. Regarding antioxidant activity, ascorbic acid had an IC50 value of 7.928 µg/ml, while the plant extracts showed varying levels of antioxidant potential, with R. damascena leaf extract having the lowest IC50 value of 21.10 µg/ml and C. grandiflorum leaf extract showing the highest IC50 value of 241.21 µg/ml. These findings indicate that the selected plants possess antimicrobial and antioxidant properties, and their phytochemical content may contribute to their therapeutic potential.

2 February 2024 in South Asian Journal of Research in Microbiology
Verified
Journal Article
Closed access
PDF file
PLPooja Lakhey
Pooja Lakhey
SPShyam Prasad Pant
Shyam Prasad Pant
PPPramila Parajuli
Pramila Parajuli
Background: Acinetobacter baumannii, an opportunistic Gram-negative pathogen, poses an escalating threat in clinical settings due to the rise of multidrug-resistant infections. Despite its clinical significance, there exists a considerable gap in understanding its environmental dissemination. Aims and Objectives: The primary objective is to examine the distribution of A. baumannii and its antibiotic resistance in river ecosystems. Specifically, we aim to identify strains resistant to Colistin, a last-resort antibiotic, and elucidate the susceptibility patterns to other antibiotics. Materials and Methods: Water samples from 10 rivers were collected and subjected to analysis using Leeds Acinetobacter Agar Base and a series of biochemical tests. Antibiotic susceptibility testing, focusing on Colistin resistance, was performed using standard procedures. Results: Out of the 284 isolated strains, 14 (4.9%) exhibited resistance to Colistin, while demonstrating varying susceptibility patterns to other antibiotics. Notably, Gentamycin showed effectiveness against resistant strains (14.28%), while Ceftazidime resistance was complete. Colistin-sensitive strains displayed high susceptibility to Ciprofloxacin (84.44%) and lower susceptibility to Chloramphenicol (53.33%). Carbapenem susceptibility was observed across all isolates. Conclusion: The study underscores a concerning environmental presence of multidrug-resistant A. baumannii in rivers around Kathmandu Valley, with Sundarijal being the exception. The findings emphasize the necessity of scrutinizing environmental reservoirs for pathogen spread, advocating for heightened awareness of potential health implications beyond clinical settings. Urgent attention is needed to comprehend and counteract the emergence and dissemination of antibiotic resistance, necessitating comprehensive strategies and continued surveillance